Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Patient-Reported Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Types and Severity of Chronic Gvhd

Saiko Kurosawa, MD, Kumi Oshima, Takuhiro Yamaguchi, Atsumi Yanagisawa, Takahiro Fukuda, Heiwa Kanamori, MD, Takehiko Mori, MD PhD, Satoshi Takahashi, MD PhD, Tadakazu Kondo, MD PhD, Akio Kohno, Aika Seto, MD, Yukari Umemoto, Takanori Teshima, MD PhD, Shuichi Taniguchi, MD PhD, Takuya Yamashita, Yoshiko Atsuta, MD PhD

Blood (2016) 128 (22): 1240.

https://doi.org/10.1182/blood.V128.22.1240.1240

Published: 2016

Journal Articles

Decision Analysis of Allogeneic Hematopoietic Stem Cell Transplantation Versus Chemotherapy in Cytogenetically Standard-Risk Acute Myeloid Leukemia in First Complete Remission: The Impact of FLT3-ITD Profile

Blood (2014) 124 (21): 1221.

https://doi.org/10.1182/blood.V124.21.1221.1221

Published: 2014

Journal Articles

Gvhd Prophylaxis With Mycophenolate Mofetil and Calcineurin Inhibitor In Allogeneic Hematopoietic Cell Transplantation From HLA-Matched Siblings Or 7–8/8 HLA-Matched Unrelated Volunteer Donors: A Japanese, Multicenter, Phase II Trial

Takahiko Nakane, M.D., Ph.D., Hirohisa Nakamae, MD, PhD, Saiko Kurosawa, MD, Atsuo Okamura, MD, PhD, Michihiro Hidaka, MD, PhD, Takuya Yamashita, MD, PhD, Akio Kohno, MD, PhD, Takeshi Saito, MD, Yasutaka Aoyama, MD, PhD, Kazuo Hatanaka, MD, Yoshio Katayama, MD, PhD, Kimikazu Yakushijin, MD, PhD, Toshimitsu Matsui, MD, PhD, Akiyoshi Takami, MD, PhD, Takuhiro Yamaguchi, PhD, Masayuki Hino, MD, PhD, Takahiro Fukuda, MD

Blood (2013) 122 (21): 4586.

https://doi.org/10.1182/blood.V122.21.4586.4586

Published: 2013

Journal Articles

Cytomegalovirus Reactivation After Allogeneic Stem Cell Transplantation Is Associated With a Reduced Risk Of Relapse In Patients With Acute Myeloid Leukemia: The Japan Society For Hematopoietic Cell Transplantation (JSHCT) Transplantation-Related Complication Working Group

Katsuto Takenaka, M.D., PhD, Tetsuya Nishida, MD, PhD, Yuki Asano-Mori, MD, PhD, Kumi Oshima, MD, Gaku Oshikawa, MD, Koichi Miyamura, MD, PhD, Tetsuya Eto, MD, PhD, Hirohisa Nakamae, MD, PhD, Hisashi Sakamaki, MD, PhD, Yasuo Morishima, MD, Ritsuro Suzuki, MD, Takuhiro Yamaguchi, Ph.D., Takahiro Fukuda, MD

Blood (2013) 122 (21): 915.

https://doi.org/10.1182/blood.V122.21.915.915

Published: 2013

Journal Articles

Matched HLA Haplotype Contributes to Reduce Sever Acute GVHD with Conserving GVL Effect in HLA-Mismatched Cord Blood Transplantation,

Satoshi Takahashi, M.D., Ph.D., Jun Ooi, MD, Seiko Kato, M.D., Toshiro Kawakita, M.D., Arinobu Tojo, MD, PhD, Yasuhiro Ebihara, MD, PhD, Shinji Mochizuki, MD, PhD, Shohei Yamamoto, MD, PhD, Kohichiro Tsuji, MD, PhD, Takuhiro Yamaguchi, Ph.D., Satoko Morishima, MD., Ph.D., Yasuo Morishima, MD, PhD, Shigetaka Asano, MD

Blood (2011) 118 (21): 4140.

https://doi.org/10.1182/blood.V118.21.4140.4140

Published: 2011

Journal Articles

A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission

Saiko Kurosawa, Takuhiro Yamaguchi, Shuichi Miyawaki, Naoyuki Uchida, Heiwa Kanamori, Kensuke Usuki, Takuya Yamashita, Masato Watanabe, Kazuaki Yakushiji, Shingo Yano, Yuichiro Nawa, Jun Taguchi, Jin Takeuchi, Junji Tomiyama, Yuko Nakamura, Ikuo Miura, Yoshinobu Kanda, Yoichi Takaue, Takahiro Fukuda

Blood (2011) 117 (7): 2113–2120.

https://doi.org/10.1182/blood-2010-05-285502

Published: 2011

Includes: Supplemental data

Journal Articles

Changes In Incidence and Causes of Non-Relapse Mortality (NRM) After Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Are Transplants Improving?

Saiko Kurosawa, Kimikazu Yakushijin, Takuhiro Yamaguchi, Yoshiko Atsuta, Tokiko Nagamura-Inoue, Hideki Akiyama, Shuichi Taniguchi, Koichi Miyamura, Satoshi Takahashi, Tetsuya Eto, Yasuo Morishima, MD, Hisashi Sakamaki, Takahiro Fukuda

Blood (2010) 116 (21): 901.

https://doi.org/10.1182/blood.V116.21.901.901

Published: 2010

Journal Articles

The Impact of HLA Haplotype Matching for Mismatched Cord Blood Transplantation.

Satoshi Takahashi, M.D., Jun Ooi, M.D., Nobuhiro Tsukada, M.D., Seiko Kato, M.D., Aki Sato, M.D., Toshiro Kawakita, M.D., Yasuyuki Nagata, M.D., Maki Monna-Ooiwa, Arinobu Tojo, MD, Takuhiro Yamaguchi, Ph.D., Satoko Morishima, M.D., Yasuo Morishima, M.D., Shigetaka Asano, M.D.

Blood (2009) 114 (22): 1206.

https://doi.org/10.1182/blood.V114.22.1206.1206

Published: 2009

Journal Articles

A Markov Decision Analysis of Post-Remission Strategies in 2029 Patients with AML in First Remission (CR1): Should We Perform Allogeneic Hematopoietic Cell Transplantation in CR1?.

Blood (2009) 114 (22): 2281.

https://doi.org/10.1182/blood.V114.22.2281.2281

Published: 2009

Journal Articles

Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy as Post-Remission Strategy in Elderly Patients with Non-M3 AML in CR1: Retrospective Analysis with 1036 Patients.

Saiko Kurosawa, Takuhiro Yamaguchi, Naoyuki Uchida, Toru Sakura, Kensuke Usuki, Masato Watanabe, Takuya Yamashita, Heiwa Kanamori, Junji Tomiyama, Yuichiro Nawa, Shingo Yano, Jin Takeuchi, Kazuaki Yakushiji, Fumiaki Sano, Nobuhiko Uoshima, Yasuhito Nannya, Yoshiyuki Moriuchi, Yoichi Takaue, Takahiro Fukuda

Blood (2009) 114 (22): 524.

https://doi.org/10.1182/blood.V114.22.524.524

Published: 2009

Journal Articles

A Randomized Trial Comparing Individualized Vs. Non-Individualized Treatment for Elderly Acute Myeloid Leukemia: JALSG GML200 Study

Atsushi Wakita, MD, Shigeki Ohtake, MD, Satoru Takada, MD, Fumiharu Yagasaki, MD, Hirokazu Komatsu, MD, Yasushi Miyazaki, MD, Koumei Kubo, MD, Yukihiko Kimura, MD, Akihiro Takeshita, MD, Yoko Adachi, MD, Hitoshi Kiyoi, MD, Takuhiro Yamaguchi, PhD, Minoru Yoshida, MD, Kazunori Ohnishi, MD, Shuichi Miyawaki, MD, Tomoki Naoe, MD, Ryuzo Ueda, MD, Ryuzo Ohno, MD

Blood (2008) 112 (11): 2961.

https://doi.org/10.1182/blood.V112.11.2961.2961

Published: 2008

Journal Articles

Contribution of HLA Incompatibility on Clinical Outcomes of CBT in Patients with MDS Including Secondary AML in Japan: Multivariate Analysis Using Competing Risk Regression Model

Satoshi Takahashi, MD, Takuhiro Yamaguchi, PhD, Maki Monna-Ooiwa, Shuichi Taniguchi, MD, Hisashi Sakamaki, MD, PhD, Takeshi Morii, MD, Yoshihisa Nagatoshi, MD, Nobuyuki Aotsuka, MD, Shunichi Kato, MD, Minoko Takanashi, MD, Tokiko Nagamura, MD, Hiroshi Azuma, PhD, Shunro Kai, MD, Koji Kato, MD, Shigetaka Asano, MD

Blood (2008) 112 (11): 3004.

https://doi.org/10.1182/blood.V112.11.3004.3004

Published: 2008

Journal Articles

Chronic graft-versus-host disease following umbilical cord blood transplantation: retrospective survey involving 1072 patients in Japan

Blood (2008) 112 (6): 2579–2582.

https://doi.org/10.1182/blood-2007-11-118893

Published: 2008

Includes: Supplemental data

Journal Articles

Unrelated Cord Blood Transplanation for Malignant Lymphoma: A Retrospective Study from the Japan Cord Blood Bank Network (JCBNW).

Morihito Takita, MD, Koichiro Yuji, MD, Takuhiro Yamaguchi, PhD, Tomoko Matsumura, MD, Masahiro Kami, MD, Hisashi Sakamaki, MD, Yasushi Kouzai, MD, Masaya Okada, MD, Yuko Osugi, MD, Ryuji Kobayashi, MD, Masami Inoue, MD, Satoshi Takahashi, MD, Makoto Murata, MD, Shunro Kai, MD, Koji Kato, MD, Tokiko Nagamura, MD, Shuichi Taniguchi, MD, Shunichi Kato, MD

Blood (2007) 110 (11): 2026.

https://doi.org/10.1182/blood.V110.11.2026.2026

Published: 2007

Journal Articles

The Comparative Analysis of Bone Marrow Transplantation and Cord Blood Transplantation from Unrelated Donors in Patients with Myelodysplastic Syndrome in Japan.

Satoshi Takahashi, MD, Takuhiro Yamaguchi, Ph.D., Jun Ooi, M.D., Akira Tomonari, M.D., Nobuhiro Tsukada, M.D., Takaaki Konuma, M.D., Tokiko Nagamura, M.D., Shunichi Kato, M.D., Takakazu Kawase, M.D., Yasuo Morishima, M.D., Shigetaka Asano, M.D.

Blood (2007) 110 (11): 2012.

https://doi.org/10.1182/blood.V110.11.2012.2012

Published: 2007

Journal Articles

Unrelated Cord Blood Transplantation Using Myeloablative Regimen for Acute Leukemia Patients Aged between 50 and 55 Years: Single Institutional Retrospective Comparison with Patients Less Than 50 Years of Age.

Takaaki Konuma, Satoshi Takahashi, Jun Ooi, Akira Tomonari, Nobuhiro Tsukada, Seiko Kato, Maki Oiwa-Monna, Kaoru Uchimaru, Arinobu Tojo, Takuhiro Yamaguchi, Shigetaka Asano

Blood (2007) 110 (11): 2013.

https://doi.org/10.1182/blood.V110.11.2013.2013

Published: 2007

Journal Articles

Acute Graft-Versus-Host Disease Following Umbilical Cord Blood Transplantation: Retrospective Survey Involving 2015 Japanese Patients.

Blood (2007) 110 (11): 1070.

https://doi.org/10.1182/blood.V110.11.1070.1070

Published: 2007

Journal Articles

Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen

Satoshi Takahashi, Jun Ooi, Akira Tomonari, Takaaki Konuma, Nobuhiro Tsukada, Maki Oiwa-Monna, Kenji Fukuno, Michihiro Uchiyama, Kashiya Takasugi, Tohru Iseki, Arinobu Tojo, Takuhiro Yamaguchi, Shigetaka Asano

Blood (2006) 109 (3): 1322–1330.

https://doi.org/10.1182/blood-2006-04-020172

Published: 2006

Journal Articles

Clinical Outcomes of Cord Blood Transplantation from Unrelated Donors Comparable with Marrow or Blood Transplantation from Related Donors in Adults: A Single Institute Analysis.

Satoshi Takahashi, MD, Jun Ooi, MD, Akira Tomonari, MD, Takaaki Konuma, MD, Kenji Fukuno, MD, Nobuhiro Tsukada, MD, Maki Monna-Ooiwa, Takuhiro Yamaguchi, PhD, Arinobu Tojo, MD, Shigetaka Asano, MD

Blood (2005) 106 (11): 306.

https://doi.org/10.1182/blood.V106.11.306.306

Published: 2005

Journal Articles

Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies

Satoshi Takahashi, Tohru Iseki, Jun Ooi, Akira Tomonari, Kashiya Takasugi, Yoko Shimohakamada, Toshiki Yamada, Kaoru Uchimaru, Arinobu Tojo, Naoki Shirafuji, Hideki Kodo, Kenzaburo Tani, Tsuneo Takahashi, Takuhiro Yamaguchi, Shigetaka Asano

Blood (2004) 104 (12): 3813–3820.

https://doi.org/10.1182/blood-2004-03-1001

Published: 2004

NARROW

Patient-Reported Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Types and Severity of Chronic Gvhd

Decision Analysis of Allogeneic Hematopoietic Stem Cell Transplantation Versus Chemotherapy in Cytogenetically Standard-Risk Acute Myeloid Leukemia in First Complete Remission: The Impact of FLT3-ITD Profile

Gvhd Prophylaxis With Mycophenolate Mofetil and Calcineurin Inhibitor In Allogeneic Hematopoietic Cell Transplantation From HLA-Matched Siblings Or 7–8/8 HLA-Matched Unrelated Volunteer Donors: A Japanese, Multicenter, Phase II Trial

Cytomegalovirus Reactivation After Allogeneic Stem Cell Transplantation Is Associated With a Reduced Risk Of Relapse In Patients With Acute Myeloid Leukemia: The Japan Society For Hematopoietic Cell Transplantation (JSHCT) Transplantation-Related Complication Working Group

Matched HLA Haplotype Contributes to Reduce Sever Acute GVHD with Conserving GVL Effect in HLA-Mismatched Cord Blood Transplantation,

A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission

Changes In Incidence and Causes of Non-Relapse Mortality (NRM) After Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Are Transplants Improving?

The Impact of HLA Haplotype Matching for Mismatched Cord Blood Transplantation.

A Markov Decision Analysis of Post-Remission Strategies in 2029 Patients with AML in First Remission (CR1): Should We Perform Allogeneic Hematopoietic Cell Transplantation in CR1?.

Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy as Post-Remission Strategy in Elderly Patients with Non-M3 AML in CR1: Retrospective Analysis with 1036 Patients.

A Randomized Trial Comparing Individualized Vs. Non-Individualized Treatment for Elderly Acute Myeloid Leukemia: JALSG GML200 Study

Contribution of HLA Incompatibility on Clinical Outcomes of CBT in Patients with MDS Including Secondary AML in Japan: Multivariate Analysis Using Competing Risk Regression Model

Chronic graft-versus-host disease following umbilical cord blood transplantation: retrospective survey involving 1072 patients in Japan

Unrelated Cord Blood Transplanation for Malignant Lymphoma: A Retrospective Study from the Japan Cord Blood Bank Network (JCBNW).

The Comparative Analysis of Bone Marrow Transplantation and Cord Blood Transplantation from Unrelated Donors in Patients with Myelodysplastic Syndrome in Japan.

Unrelated Cord Blood Transplantation Using Myeloablative Regimen for Acute Leukemia Patients Aged between 50 and 55 Years: Single Institutional Retrospective Comparison with Patients Less Than 50 Years of Age.

Acute Graft-Versus-Host Disease Following Umbilical Cord Blood Transplantation: Retrospective Survey Involving 2015 Japanese Patients.

Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen

Clinical Outcomes of Cord Blood Transplantation from Unrelated Donors Comparable with Marrow or Blood Transplantation from Related Donors in Adults: A Single Institute Analysis.

Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only